Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session

Gainers Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022.

Benzinga

Walmart, Shopify And Some Other Big Stocks Recording Losses On Tuesday

U.S. stocks closed lower on Monday, with the Nasdaq Composite dropping more than 200 points. Here is the list of some big stocks moving lower in the previous session.

Benzinga

Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Scheduled For July 27, 2022

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.

Benzinga

Bitcoin, Ethereum, Dogecoin Shrug Off Tech Earnings For Now: Analyst Asks 'Does FOMC Matter To BTC?'

Bitcoin and Ethereum traded in the green on Tuesday evening as the global cryptocurrency market cap fell 0.8% to $974.3 billion at press time.

Benzinga

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Benzinga

Putin, Russia Pulling Out Of International Space Station After 2024: Elon Musk Had This To Say About It

The largest country is Europe by land size announced plans to end its cooperation on one of the key pieces to space exploration and data collection Tuesday.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Is Microsoft Charged Up For A Move? How The Stock Looks Going Into Q4 Earnings Print

Microsoft Corporation (NASDAQ: MSFT) is set to print its fiscal fourth-quarter and full-year financial results after the market closes on Tuesday. The stock was trading about 3.5% lower heading into the event.

Benzinga

What The Chart Says About Alphabet (GOOGL) Stock Before And After Q2 Earnings Report

Alphabet, Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) will print its second-quarter earnings after the bell on Tuesday.

Benzinga

Palantir Stock Is Showing Signs Of Life

Enterprise and government data analytics services provider Palantir Technologies (NASDAQ: PLTR) stock has plummeted nearly (-46%) in 2022. According to its CEO Alex Karp, Palantir thrives in both good and bad times. He claims they predicted inflation and built the Company to had free cash flow, not just growth.

Benzinga

Crude Oil Drops 1%; General Motors Earnings Miss Views

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Tuesday.

Benzinga

10 Information Technology Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

What To Expect From Apple's Upcoming Earnings Report

All eyes will be set on the earnings of tech heavyweights including Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT) and Apple (NASDAQ: AAPL) this week.

Benzinga

10 Consumer Discretionary Stocks Whale Activity In Today's Session

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Benzinga

Nasdaq Tumbles 200 Points; McDonald's Posts Upbeat Q2 Earnings

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 200 points on Tuesday.

Benzinga

Hello Kitty NFTs Are Coming: Here Are The Details

Hello Kitty and Friends are coming to the world of non-fungible tokens (NFTs). Here are the details of the partnership between Hello Kitty parent Sanrio and NFT company Recur.

Benzinga

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 120 companies achieved new lows for the year.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Nasdaq And 2 Other Stocks Insiders Are Selling

US gold futures traded mostly flat on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022

Upgrades

Benzinga

Dow Drops Over 100 Points; Coca-Cola Tops Q2 Views

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday.

Benzinga

Why Vinco Ventures Shares Are Falling Tuesday

Digital media and content company Vinco Ventures (NASDAQ: BBIG) is seeing shares drop Tuesday morning after several press releases were issued Monday.

Benzinga

Want To Buy A Used Tesla? Better Act Fast, Here's How Long They Last On Market On Average

Electric vehicle leader Tesla Inc (NASDAQ: TSLA) recently reported quarterly financial results that saw second quarter deliveries and production up 27% and 25% respectively on a year-over-year basis.

Benzinga

EXCLUSIVE: SOBRsafe Launches Wearable Alcohol Monitoring Band In Partnership With North-Star Care

SOBR Safe, Inc (NASDAQ: SOBR) launches an alcohol monitoring band for alcohol treatment programs, SOBRsure.

Benzinga

Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

1 … 311 312 313 314

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.